Trial Profile
A Randomised, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Trial of Anti-C5aR Antibody (NNC 0151-0000-0000) Administered by i.v. Infusion or s.c. Injection in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Feb 2017
Price :
$35
*